Literature DB >> 24426334

Improvement of chronic osteomyelitis after granulocyte colony stimulating factor.

Michael I Pearce1, Ann Cuthbert2, Guy Porter3, Paul R J Ames2.   

Abstract

BACKGROUND: chronic osteomyelitis represents a persistent bone and bone marrow infection easy to diagnose in the presence of pain, erythema, swelling, and a draining sinus but more difficult to detect in the absence of the preceding features and with a painful orthopaedic prosthesis. CASE DESCRIPTION: we report upon an elderly gentleman with myelodysplasia requiring revision surgery for a fractured prosthetic left knee. He had clinical, laboratory, and radiological features of chronic osteomyelitis that improved only with administration of granulocyte colony stimulating factor (G-CSF). LITERATURE REVIEW: G-CSF has been successfully employed to treat resistant osteomyelitis in three young patients with primary defects of monocyte and neutrophil killing. A randomized trial confirmed the efficacy of G-CSF in the treatment of chronic osteomyelitis in twenty patients with diabetic foot ulcers and a rat model confirmed the efficacy of G-CSF in acute osteomyelitis. CLINICAL RELEVANCE: our case highlights the usefulness of G-CSF treatment for immune suppressed patients with resistant chronic osteomyelitis.

Entities:  

Year:  2011        PMID: 24426334      PMCID: PMC3572250          DOI: 10.1007/s12288-011-0127-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  9 in total

Review 1.  Adult osteomyelitis.

Authors:  Jason H Calhoun; M M Manring
Journal:  Infect Dis Clin North Am       Date:  2005-12       Impact factor: 5.982

2.  Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease.

Authors:  J Dotis; P Panagopoulou; J Filioti; R Winn; C Toptsis; C Panteliadis; E Roilides
Journal:  Infection       Date:  2003-03       Impact factor: 3.553

3.  Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.

Authors:  F de Lalla; G Pellizzer; M Strazzabosco; Z Martini; G Du Jardin; L Lora; P Fabris; P Benedetti; G Erle
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Effect of granulocyte-macrophage colony-stimulating factor on treatment of acute osteomyelitis. An experimental investigation in rats.

Authors:  M Subasi; A Kapukaya; C Kesemenli; H Kaya; I Sari
Journal:  Arch Orthop Trauma Surg       Date:  2001       Impact factor: 3.067

Review 5.  Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions.

Authors:  G Carulli
Journal:  Haematologica       Date:  1997 Sep-Oct       Impact factor: 9.941

6.  Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy.

Authors:  L Abu Jawdeh; R Haidar; F Bitar; S Mroueh; S Akel; N Nuwayri-Salti; G S Dbaibo
Journal:  J Infect       Date:  2000-07       Impact factor: 6.072

7.  Treatment with rhG-CSF for osteomyelitis in a patient with p47-phox-deficient chronic granulomatous disease.

Authors:  H Isotani; Y Fukumoto; H Kawamura; M Sasada; K Hattori; T Fujiwara; Y Kobayashi
Journal:  Ann Hematol       Date:  1997 Nov-Dec       Impact factor: 3.673

8.  Blood neutrophil function in primary myelodysplastic syndromes.

Authors:  M A Boogaerts; V Nelissen; C Roelant; W Goossens
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

Review 9.  Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.

Authors:  Paolo Anderlini; Richard E Champlin
Journal:  Blood       Date:  2007-12-05       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.